Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R de Groot

Showing results (491-500 of 568) with videos related to

Pageof 57
Sort By:
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 22, 2023
The influence of atrial high-rate episodes on stroke and cardiovascular death: an updateTobias Toennis, Emanuele Bertaglia, Axel Brandes, et al.
BMC Cardiovascular Disorders|July 14, 2019
Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe)Raffaele De Caterina, Peter Kelly, Pedro Monteiro, et al.
American Journal of Human Genetics|August 27, 1998
Localization of the ICF syndrome to chromosome 20 by homozygosity mappingC Wijmenga, L P van den Heuvel, E Strengman, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 26, 2022
Edoxaban for stroke prevention in atrial fibrillation and age-adjusted predictors of clinical outcomes in routine clinical carePaulus Kirchhof, Ladislav Pecen, Ameet Bakhai, et al.
Journal of the American College of Cardiology|September 10, 2016
Ganglion Plexus Ablation in Advanced Atrial Fibrillation: The AFACT StudyAntoine H G Driessen, Wouter R Berger, Sébastien P J Krul, et al.
Heart Rhythm|March 25, 2020
Cardiac radioablation-A systematic reviewMartijn H van der Ree, Oliver Blanck, Jacqueline Limpens, et al.
Circulation. Arrhythmia and Electrophysiology|November 19, 2011
Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks?Zeliha Koyak, Joris R de Groot, Isabelle C Van Gelder, et al.
Journal of the American College of Cardiology|October 16, 2012
The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohortLouise R A Olde Nordkamp, Lara Dabiri Abkenari, Lucas V A Boersma, et al.
Journal of Cardiovascular Electrophysiology|March 8, 2022
Strategies for repeat ablation for atrial fibrillation: A multicentre comparison of nonpulmonary vein versus pulmonary vein target ablationDaniel Mol, Mark J Mulder, Rob Veenstra, et al.
AIDS (London, England)|December 2, 1998
Early recovery of CD4+ T lymphocytes in children on highly active antiretroviral therapy. Dutch study group for children with HIV infectionsJ W Cohen Stuart, W A Slieker, G T Rijkers, et al.
Pageof 57

Showing results (491-500 of 568) with videos related to

Sort By:
Pageof 57
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 22, 2023
The influence of atrial high-rate episodes on stroke and cardiovascular death: an updateTobias Toennis, Emanuele Bertaglia, Axel Brandes, et al.
BMC Cardiovascular Disorders|July 14, 2019
Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe)Raffaele De Caterina, Peter Kelly, Pedro Monteiro, et al.
American Journal of Human Genetics|August 27, 1998
Localization of the ICF syndrome to chromosome 20 by homozygosity mappingC Wijmenga, L P van den Heuvel, E Strengman, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 26, 2022
Edoxaban for stroke prevention in atrial fibrillation and age-adjusted predictors of clinical outcomes in routine clinical carePaulus Kirchhof, Ladislav Pecen, Ameet Bakhai, et al.
Journal of the American College of Cardiology|September 10, 2016
Ganglion Plexus Ablation in Advanced Atrial Fibrillation: The AFACT StudyAntoine H G Driessen, Wouter R Berger, Sébastien P J Krul, et al.
Heart Rhythm|March 25, 2020
Cardiac radioablation-A systematic reviewMartijn H van der Ree, Oliver Blanck, Jacqueline Limpens, et al.
Circulation. Arrhythmia and Electrophysiology|November 19, 2011
Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks?Zeliha Koyak, Joris R de Groot, Isabelle C Van Gelder, et al.
Journal of the American College of Cardiology|October 16, 2012
The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohortLouise R A Olde Nordkamp, Lara Dabiri Abkenari, Lucas V A Boersma, et al.
Journal of Cardiovascular Electrophysiology|March 8, 2022
Strategies for repeat ablation for atrial fibrillation: A multicentre comparison of nonpulmonary vein versus pulmonary vein target ablationDaniel Mol, Mark J Mulder, Rob Veenstra, et al.
AIDS (London, England)|December 2, 1998
Early recovery of CD4+ T lymphocytes in children on highly active antiretroviral therapy. Dutch study group for children with HIV infectionsJ W Cohen Stuart, W A Slieker, G T Rijkers, et al.
Pageof 57